ZA202205263B - Solid pharmaceutical forms of perampanel - Google Patents

Solid pharmaceutical forms of perampanel

Info

Publication number
ZA202205263B
ZA202205263B ZA2022/05263A ZA202205263A ZA202205263B ZA 202205263 B ZA202205263 B ZA 202205263B ZA 2022/05263 A ZA2022/05263 A ZA 2022/05263A ZA 202205263 A ZA202205263 A ZA 202205263A ZA 202205263 B ZA202205263 B ZA 202205263B
Authority
ZA
South Africa
Prior art keywords
perampanel
solid pharmaceutical
pharmaceutical forms
forms
solid
Prior art date
Application number
ZA2022/05263A
Inventor
Ergina Pentafragka
Stella Matthaiou
Pavlos Papalekakos
Original Assignee
Elpen S A Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elpen S A Pharmaceutical Ind filed Critical Elpen S A Pharmaceutical Ind
Publication of ZA202205263B publication Critical patent/ZA202205263B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA2022/05263A 2021-05-31 2022-05-12 Solid pharmaceutical forms of perampanel ZA202205263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20210100360A GR1010285B (en) 2021-05-31 2021-05-31 Solid pharmaceutical forms of perampanel

Publications (1)

Publication Number Publication Date
ZA202205263B true ZA202205263B (en) 2023-01-25

Family

ID=83192224

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/05263A ZA202205263B (en) 2021-05-31 2022-05-12 Solid pharmaceutical forms of perampanel

Country Status (2)

Country Link
GR (1) GR1010285B (en)
ZA (1) ZA202205263B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148809A (en) * 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
WO2009054544A1 (en) * 2007-10-26 2009-04-30 Eisai R & D Management Co., Ltd. Ampa receptor antagonists for parkinson's disease and movement disorders
EP2800747A4 (en) * 2012-01-03 2015-12-09 Mapi Pharma Ltd Polymorphs of perampanel
CN106389367B (en) * 2016-11-16 2020-12-18 杭州朱养心药业有限公司 Perampanel coated tablet pharmaceutical composition

Also Published As

Publication number Publication date
GR1010285B (en) 2022-08-24

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
EP3914252A4 (en) Pharmaceutical compositions of nilotinib
IL286218A (en) Solid state forms of ripretinib
GB202008961D0 (en) Pharmaceutical composition
ZA202203770B (en) Pharmaceutical combination of prmt5 inhibitors
EP4098258A4 (en) Pharmaceutical use of ketoamide-based compound
GB202020191D0 (en) Pharmaceutical compounds
IL279622A (en) Pharmaceutical formulations of masked antibodies
IL283286A (en) Pharmaceutical formulations of cyclosporine analogs
IL304354A (en) Solid tablet dosage form of ridinilazole
GB202010409D0 (en) Pharmaceutical compounds
ZA202205263B (en) Solid pharmaceutical forms of perampanel
EP4076442A4 (en) Pharmaceutical composition of cyclooxygenase - 2 inhibitors
GB202010408D0 (en) Pharmaceutical compounds
GB202103774D0 (en) Detectiion of Ransomware
IL311716A (en) Pharmaceutical composition of sepiapterin
GB202117969D0 (en) Pharmaceutical compounds
GB202111193D0 (en) Pharmaceutical compounds
GB202104097D0 (en) Pharmaceutical compounds
GB202102602D0 (en) Pharmaceutical compounds
GB202007163D0 (en) Pharmaceutical compounds
GB202003646D0 (en) Pharmaceutical compounds
GB202002144D0 (en) Pharmaceutical compounds
KR102423280B9 (en) Sot-mram area-optimized design of sot-mram
GB202304987D0 (en) Combination pharmaceutical